REPORT ID 4345

Global Klebsiella Pneumoniae Infection Drug Market ResearchReport 2019

Publish Date
2019
Pages
119
Format
Electronic (PDF)

In this report, the global Klebsiella Pneumoniae Infection Drug market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Klebsiella Pneumoniae Infection Drug in these regions, from   2019 to 2025 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Klebsiella Pneumoniae Infection Drug market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Acies Bio doo
    Appili Therapeutics
    Debiopharm International SA
    Evaxion Biotech ApS
    F. Hoffmann-La Roche Ltd
    FOB Synthesis Inc
    ImmunoClin Corp
    Innovation Pharmaceuticals Inc
    Kyorin Pharmaceutical Co Ltd
    Melinta Therapeutics Inc
    Nosopharm SAS
    Peptilogics Inc
    Pfizer Inc
    Phico Therapeutics Ltd
    Sarepta Therapeutics Inc
    Shionogi & Co Ltd
    Syntiron LLC
    Tetraphase Pharmaceuticals Inc
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    ATI-1503
    CA-824
    CC-1807
    Cefiderocol
    Debio-1454
    EBX-004
    Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Hospital
    Clinic
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Klebsiella Pneumoniae Infection Drug Market Research  Report 2019
1 Klebsiella Pneumoniae Infection Drug Market Overview
    1.1 Product Overview and Scope of Klebsiella Pneumoniae Infection Drug
    1.2 Klebsiella Pneumoniae Infection Drug Segment by Type (Product Category)
        1.2.1 Global Klebsiella Pneumoniae Infection Drug Production and CAGR (%) Comparison by Type (Product Category)( 2014-2024)
        1.2.2 Global Klebsiella Pneumoniae Infection Drug Production Market Share by Type (Product Category)  in 2018
        1.2.3 ATI-1503
        1.2.4 CA-824
        1.2.5 CC-1807
        1.2.6 Cefiderocol
        1.2.7 Debio-1454
        1.2.8 EBX-004
        1.2.9 Others
    1.3 Global Klebsiella Pneumoniae Infection Drug Segment by Application
        1.3.1 Klebsiella Pneumoniae Infection Drug Consumption (Sales) Comparison by Application ( 2014-2024)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Global Klebsiella Pneumoniae Infection Drug Market by Region ( 2014-2024)
        1.4.1 Global Klebsiella Pneumoniae Infection Drug Market Size (Value) and CAGR (%) Comparison by Region ( 2014-2024)
        1.4.2 North America Status and Prospect ( 2014-2024)
        1.4.3 Europe Status and Prospect ( 2014-2024)
        1.4.4 China Status and Prospect ( 2014-2024)
        1.4.5 Japan Status and Prospect ( 2014-2024)
        1.4.6 Southeast Asia Status and Prospect ( 2014-2024)
        1.4.7 India Status and Prospect ( 2014-2024)
    1.5 Global Market Size (Value) of Klebsiella Pneumoniae Infection Drug ( 2014-2024)
        1.5.1 Global Klebsiella Pneumoniae Infection Drug Revenue Status and Outlook ( 2014-2024)
        1.5.2 Global Klebsiella Pneumoniae Infection Drug Capacity, Production Status and Outlook ( 2014-2024)

2 Global Klebsiella Pneumoniae Infection Drug Market Competition by Manufacturers
    2.1 Global Klebsiella Pneumoniae Infection Drug Capacity, Production and Share by Manufacturers ( 2014-2019)
        2.1.1 Global Klebsiella Pneumoniae Infection Drug Capacity and Share by Manufacturers ( 2014-2019)
        2.1.2 Global Klebsiella Pneumoniae Infection Drug Production and Share by Manufacturers ( 2014-2019)
    2.2 Global Klebsiella Pneumoniae Infection Drug Revenue and Share by Manufacturers ( 2014-2019)
    2.3 Global Klebsiella Pneumoniae Infection Drug Average Price by Manufacturers ( 2014-2019)
    2.4 Manufacturers Klebsiella Pneumoniae Infection Drug Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Klebsiella Pneumoniae Infection Drug Market Competitive Situation and Trends
        2.5.1 Klebsiella Pneumoniae Infection Drug Market Concentration Rate
        2.5.2 Klebsiella Pneumoniae Infection Drug Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Klebsiella Pneumoniae Infection Drug Capacity, Production, Revenue (Value) by Region ( 2014-2019)
    3.1 Global Klebsiella Pneumoniae Infection Drug Capacity and Market Share by Region ( 2014-2019)
    3.2 Global Klebsiella Pneumoniae Infection Drug Production and Market Share by Region ( 2014-2019)
    3.3 Global Klebsiella Pneumoniae Infection Drug Revenue (Value) and Market Share by Region ( 2014-2019)
    3.4 Global Klebsiella Pneumoniae Infection Drug Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.5 North America Klebsiella Pneumoniae Infection Drug Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.6 Europe Klebsiella Pneumoniae Infection Drug Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.7 China Klebsiella Pneumoniae Infection Drug Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.8 Japan Klebsiella Pneumoniae Infection Drug Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.9 Southeast Asia Klebsiella Pneumoniae Infection Drug Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.10 India Klebsiella Pneumoniae Infection Drug Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)

4 Global Klebsiella Pneumoniae Infection Drug Supply (Production), Consumption, Export, Import by Region ( 2014-2019)
    4.1 Global Klebsiella Pneumoniae Infection Drug Consumption by Region ( 2014-2019)
    4.2 North America Klebsiella Pneumoniae Infection Drug Production, Consumption, Export, Import ( 2014-2019)
    4.3 Europe Klebsiella Pneumoniae Infection Drug Production, Consumption, Export, Import ( 2014-2019)
    4.4 China Klebsiella Pneumoniae Infection Drug Production, Consumption, Export, Import ( 2014-2019)
    4.5 Japan Klebsiella Pneumoniae Infection Drug Production, Consumption, Export, Import ( 2014-2019)
    4.6 Southeast Asia Klebsiella Pneumoniae Infection Drug Production, Consumption, Export, Import ( 2014-2019)
    4.7 India Klebsiella Pneumoniae Infection Drug Production, Consumption, Export, Import ( 2014-2019)

5 Global Klebsiella Pneumoniae Infection Drug Production, Revenue (Value), Price Trend by Type
    5.1 Global Klebsiella Pneumoniae Infection Drug Production and Market Share by Type ( 2014-2019)
    5.2 Global Klebsiella Pneumoniae Infection Drug Revenue and Market Share by Type ( 2014-2019)
    5.3 Global Klebsiella Pneumoniae Infection Drug Price by Type ( 2014-2019)
    5.4 Global Klebsiella Pneumoniae Infection Drug Production Growth by Type ( 2014-2019)

6 Global Klebsiella Pneumoniae Infection Drug Market Analysis by Application
    6.1 Global Klebsiella Pneumoniae Infection Drug Consumption and Market Share by Application ( 2014-2019)
    6.2 Global Klebsiella Pneumoniae Infection Drug Consumption Growth Rate by Application ( 2014-2019)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Klebsiella Pneumoniae Infection Drug Manufacturers Profiles/Analysis
    7.1 Acies Bio doo
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Acies Bio doo Klebsiella Pneumoniae Infection Drug Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.1.4 Main Business/Business Overview
    7.2 Appili Therapeutics
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Appili Therapeutics Klebsiella Pneumoniae Infection Drug Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.2.4 Main Business/Business Overview
    7.3 Debiopharm International SA
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Debiopharm International SA Klebsiella Pneumoniae Infection Drug Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.3.4 Main Business/Business Overview
    7.4 Evaxion Biotech ApS
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Evaxion Biotech ApS Klebsiella Pneumoniae Infection Drug Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.4.4 Main Business/Business Overview
    7.5 F. Hoffmann-La Roche Ltd
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 F. Hoffmann-La Roche Ltd Klebsiella Pneumoniae Infection Drug Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.5.4 Main Business/Business Overview
    7.6 FOB Synthesis Inc
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 FOB Synthesis Inc Klebsiella Pneumoniae Infection Drug Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.6.4 Main Business/Business Overview
    7.7 ImmunoClin Corp
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 ImmunoClin Corp Klebsiella Pneumoniae Infection Drug Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.7.4 Main Business/Business Overview
    7.8 Innovation Pharmaceuticals Inc
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Innovation Pharmaceuticals Inc Klebsiella Pneumoniae Infection Drug Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.8.4 Main Business/Business Overview
    7.9 Kyorin Pharmaceutical Co Ltd
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Kyorin Pharmaceutical Co Ltd Klebsiella Pneumoniae Infection Drug Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.9.4 Main Business/Business Overview
    7.10 Melinta Therapeutics Inc
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Klebsiella Pneumoniae Infection Drug Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Melinta Therapeutics Inc Klebsiella Pneumoniae Infection Drug Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.10.4 Main Business/Business Overview
    7.11 Nosopharm SAS
    7.12 Peptilogics Inc
    7.13 Pfizer Inc
    7.14 Phico Therapeutics Ltd
    7.15 Sarepta Therapeutics Inc
    7.16 Shionogi & Co Ltd
    7.17 Syntiron LLC
    7.18 Tetraphase Pharmaceuticals Inc

8 Klebsiella Pneumoniae Infection Drug Manufacturing Cost Analysis
    8.1 Klebsiella Pneumoniae Infection Drug Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Klebsiella Pneumoniae Infection Drug

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Klebsiella Pneumoniae Infection Drug Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Klebsiella Pneumoniae Infection Drug Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Klebsiella Pneumoniae Infection Drug Market Forecast ( 2019-2025)
    12.1 Global Klebsiella Pneumoniae Infection Drug Capacity, Production, Revenue Forecast ( 2019-2025)
        12.1.1 Global Klebsiella Pneumoniae Infection Drug Capacity, Production and Growth Rate Forecast ( 2019-2025)
        12.1.2 Global Klebsiella Pneumoniae Infection Drug Revenue and Growth Rate Forecast ( 2019-2025)
        12.1.3 Global Klebsiella Pneumoniae Infection Drug Price and Trend Forecast ( 2019-2025)
    12.2 Global Klebsiella Pneumoniae Infection Drug Production, Consumption , Import and Export Forecast by Region ( 2019-2025)
        12.2.1 North America Klebsiella Pneumoniae Infection Drug Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
        12.2.2 Europe Klebsiella Pneumoniae Infection Drug Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
        12.2.3 China Klebsiella Pneumoniae Infection Drug Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
        12.2.4 Japan Klebsiella Pneumoniae Infection Drug Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
        12.2.5 Southeast Asia Klebsiella Pneumoniae Infection Drug Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
        12.2.6 India Klebsiella Pneumoniae Infection Drug Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
    12.3 Global Klebsiella Pneumoniae Infection Drug Production, Revenue and Price Forecast by Type ( 2019-2025)
    12.4 Global Klebsiella Pneumoniae Infection Drug Consumption Forecast by Application ( 2019-2025)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer